Occult constipation: faecal retention as a cause of recurrent abdominal pain in children

Size: px
Start display at page:

Download "Occult constipation: faecal retention as a cause of recurrent abdominal pain in children"

Transcription

1 Eur J Pediatr (2014) 173: DOI /s ORIGINAL ARTICLE Occult constipation: faecal retention as a cause of recurrent abdominal pain in children Carolien F. M. Gijsbers & C. M. Frank Kneepkens & Yvonne Vergouwe & Hans A. Büller Received: 18 September 2013 /Accepted: 17 December 2013 /Published online: 3 January 2014 # Springer-Verlag Berlin Heidelberg 2014 Abstract Recurrent abdominal pain (RAP) in children is generally believed to be functional. In practice, many children with RAP become pain-free with laxative therapy. The aims of the study were to establish the role of (occult) constipation in RAP and to investigate whether patients diagnosed with (occult) constipation could be identified by history and physical examination. During 2 years, all patients (age 4 16 years, secondary referral) fulfilling Apley criteria of RAP were included. After exclusion of gastrointestinal infections and food intolerance, laxatives were advised when pain persisted. (Occult) constipation was defined as abdominal pain disappearing with laxative treatment and not reappearing within a 6 month follow up period ; occult constipation was diagnosed in patients who did not fulfil the Rome criteria of constipation. Two hundred children (87 M; median age 8.8 years) were evaluated. (Occult) constipation was found in 92 patients (46 %). Of these, 18 had considerable relief of pain when treated for a somatic cause but experienced complete relief only after laxative measures; they were considered to have two diagnoses. Using multivariate C. F. M. Gijsbers (*) Department of Pediatric Gastroenterology, Juliana Children s Hospital/Haga Teaching Hospital, Sportlaan 600, 2566 MJ The Hague, The Netherlands cfm.gijsbers@planet.nl C. F. M. Gijsbers c.gijsbers@hagaziekenhuis.nl C. M. F. Kneepkens Department of Pediatric Gastroenterology, VU University Medical Centre, De Boelelaan 1117, 1081 HVAmsterdam, The Netherlands Y. Vergouwe Department of Public Health, Erasmus Medical Centre, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands H. A. Büller Department of Pediatric Gastroenterology, Sophia Children s Hospital/Erasmus Medical Centre, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands analysis, a simple model was developed with cystitis in past history, early satiety and flatulence as predictors for (occult) constipation. The risk of (occult) constipation ranged from 18/ 58 if no predictor was present to 4/4 if all three were present. Conclusion: Laxatives played a pivotal role in the recovery of patients with RAP. We developed a simple model to identify patients at risk of having (occult) constipation. Keywords Chronic abdominal pain. Functional abdominal pain. Constipation. Occult constipation. Children Introduction Recurrent abdominal pain (RAP) as defined by Apley [1] isfoundin10 15 % of 4 16-year-old children, with considerable morbidity. RAP often has a great impact on the life of the child and his family and frequently causes much anxiety [2]. In most patients, RAP is considered a functional problem. Conventional therapy, consisting of reassurance and advice on lifestyle and feeding habits, has only limited success [6]. In the 1990 s, the first Rome criteria for functional gastrointestinal disorders (FGIDs), including functional abdominal pain and functional constipation, were published in order to come to more uniform patient groups as a basis for research, followed by specific criteria for children in the second version of the Rome criteria ( Rome II criteria ). This has resulted in an enormous increase in research, which until now, however, did not lead to satisfactory advice on therapy for patients with functional abdominal pain [3]. The relation between abdominal pain and constipation remains a matter of controversy. While some consider constipation a frequent (and treatable) cause of abdominal pain, others feel that the diagnosis of constipation should be confined to children who fulfil the Rome criteria. Studies with respect to constipation and laxative therapy in relation to

2 782 Eur J Pediatr (2014) 173: abdominal pain are remarkably scarce [2,4,10,15]. We found that even patients with abdominal pain without diagnostic clues for functional constipation according to the Rome criteria could become pain-free with laxative therapy. For this condition we reintroduced the term occult constipation [8]. As this was in line with an early report showing that many children with RAP become pain-free with laxatives [10], we evaluated the effect of laxatives in children with RAP who participated in a comprehensive study on the somatic causes of RAP [7,8]. The first aim of this study was to establish the role of (occult) constipation in RAP. The second aim was to investigate whether patients diagnosed with (occult) constipation could be identified based on history and physical examination. Materials and methods From May 2002 until May 2004, all consecutive patients (ages years) referred by general practitioners to a secondary paediatric centre (CFMG) with RAP (which was defined by the Apley criteria: abdominal pain for at least 3 months; at least three bouts of pain, severe enough to interfere with daily activities) as the main presenting symptom, were included in the study. Somatic causes were excluded by evaluation in a standardized way as described previously (Table 1), resulting in the establishment of preliminary diagnoses and diagnostic clues, such as protozoan infection, celiac disease and lactose intolerance [8,9]. A causal relation of these with the abdominal pain was assumed when the patient fulfilled the criteria described in Table 2 [8]. In order to avoid bias in case of more than one diagnostic clue, interventions were performed in a fixed order, without clinical interpretation or weighing of history or Table 1 Diagnostic work-up Standardized history Physical examination Ancillary tests Blood: Blood cell count, liver enzymes, creatinine, amylase, albumin, calcium, phosphate, RAST for a panel of food allergens, anti-tissue transglutaminase antibodies (IgA) and total IgA, Yersinia serology (immunoblot) Urine: Screening, culture Faeces: Culture, Helicobacter pylori antigen, Triple Faeces Test (for protozoa) Hydrogen breath tests Lactose and fructose breath tests Radiology: Plain abdominal X-ray, abdominal ultrasound physical findings. As the first step, gastrointestinal infections and food allergy/intolerance, respectively, were treated if present. In case of persistent symptoms following these interventions, somatic causes were assumed to be sufficiently excluded (for the time being). As the second step, a trial with laxatives was performed, combined with advice on diet and toilet training, irrespective of history, physical examination or the outcome of plain abdominal X-ray [8]. Oral macrogol 4000 (polyethylene glycol 4000) was prescribed in a daily dose of 1 g/kg (maximum 40 g), the parents being advised to adjust the dose according to the resulting defaecation pattern. Some patients used other laxatives, especially lactulose or lactitol, as to their preference, with the same instructions. Frequent telephone contacts were used to support the parents with respect to laxative dosage. In case of insufficient result of oral laxatives, lavage of the colon was performed with polyethylene glycol electrolyte solution. (Occult) constipation was considered to be the cause of RAP when the pain disappeared with laxative treatment for a period of at least 6 months (Table 2). Constipation was diagnosed in those children who fulfilled the Rome II criteria for functional constipation (Table 3) [12]. Occult constipation was diagnosed in children who did not fulfil the Rome II criteria for functional constipation but had relieve of their symptoms with laxative treatment [8]. Rome II criteria for functional constipation were used because Rome III criteria were not yet published at the time of inclusion of patients. Table 2 Criteria for diagnoses General Based on intervention and follow-up, a causal relation of a specific disease or condition with abdominal pain is supposed if the following criteria are fulfilled: 1. Elimination of the cause of the pain (by therapeutic intervention) should lead to disappearance of the pain 2. The pain should disappear at an adequate moment after intervention (different per diagnosis) for optimal prevention of mistaking spontaneous recovery for the supposed diagnosis 3. The diagnosis should hold during a follow-up of at least 6 months (RAP does not reappear within a 6-month follow-up period or RAP reappears within 6 months, apparently due to the same cause and eliminated in the same way) for optimal exclusion of placebo effect Constipation and occult constipation Abdominal pain disappears with (laxative measures leading to) production of more faeces than before, regardless the kind of the measures. Treatment may need to be continued throughout the follow-up period. Pain may return upon reduction or discontinuation of treatment but disappears again with laxative treatment Constipation: those children who fulfil the Rome II criteria for functional constipation Occult constipation: those children who do not fulfil the Rome II criteria for functional constipation but show relieve of symptoms with laxative treatment

3 Eur J Pediatr (2014) 173: Table 3 Rome II criteria: functional constipation Scybalous, pebble-like, hard stools for a majority of stools, or Firm stools 2 per week; and No evidence of structural, endocrine or metabolic disease Statistical analysis Some patient characteristics were relatively rare. We therefore used Fisher s exact test to assess the univariate association for the 18 variables with (occult) constipation [5]. We combined the three variables that showed the strongest association with (occult) constipation in a simple model. Each included variable was assigned an equal weight (a score of 1). The total score was related to the observed proportion of (occult) constipation. Results Two hundred twenty children were enrolled, of whom 20 were lost to follow-up, leaving 200 patients (113 girls, 87 boys; median age 8.8 [range ], for analysis. Laxative therapy was advised to 111 patients and was successful in 92 patients (83 %; 59 girls, 33 boys), patients being pain-free with therapy. In 14 patients, laxatives were not successful, and in 5 patients, no conclusion was possible because they performed the therapeutic measures insufficiently. Of the 14 patients in whom laxative therapy was not successful, 6 patients had a somatic diagnosis, 3 were considered to have stress-related abdominal pain, 2 recovered spontaneously and 3 had no certain diagnosis or had their pain unresolved. Eighteen of the 92 patients had had previous treatment for a somatic cause, including gastrointestinal infection (15 patients) and food allergy (2 patients), or had discontinued medication (1 patient; amitriptyline), which had led to persistent considerable relief of symptoms; but as they only had complete relief of pain after additional treatment with laxatives, they were considered to have two diagnoses. All 92 patients were pain-free with laxative treatment for at least 6 months and therefore, according to our definition, were considered to have constipation or occult constipation as the cause of the abdominal pain. Most children needed g of macrogol per day, but there was considerable variation in the time (up to 4 weeks) and laxative dose (up to 70 g per day) needed to obtain success; 8 patients needed colonic lavage to obtain sufficient result. The median follow-up period of the patients with (occult) constipation was 11 (range 6 48) months. Of the 92 children who were successfully treated with laxatives, as proven by a 6-month pain-free follow-up, 24 fulfilled Rome II criteria for functional constipation and therefore were considered to have functional constipation. The other 68 children, who were pain-free with laxatives but did not fulfil the Rome II criteria for functional constipation, by definition were considered to have occult constipation. Of the 46 patients who fulfilled the Rome II criteria for functional constipation, 9 had a somatic diagnosis for the abdominal pain; they became pain-free with intervention for a somatic disorder without laxative treatment. Table 4 shows the univariate association of the patient characteristics with (occult) constipation. Cystitis (past history), early satiety, flatulence, change in consistency at the onset of pain, the sensation of incomplete evacuation and the sensation of abdominal fullness were more common in patients with (occult) constipation than in patients without constipation. The three manifestations with the strongest association, i.e. cystitis (past history), early satiety and flatulence, were combined in a model, resulting in a scoring system. Table 5 shows the link between the scores and (occult) constipation. Higher scores were related to higher risks of (occult) constipation: 18 of 58 patients with a score of 0 had (occult) constipation compared to 4 of the 4 patients with a score of 3. Discussion The present study is part of a comprehensive research program aiming at finding definite diagnoses for RAP in a large group of children. In this study, resolution of abdominal pain was obtained in 198 (99 %) of 200 patients [8]. In 92 of these patients (46 %), a diagnosis of functional or occult constipation was made, according to preset criteria. It should be realised that a diagnosis of functional constipation according to the Rome criteria does not guarantee a causal relation with the abdominal pain: as in other diagnoses that potentially can cause RAP, such as celiac disease or parasites, the causal relation has to be made plausible by therapeutic intervention and a pain-free follow-up period. In this study, we found 9 out of the 46 patients who fulfilled the Rome II criteria of functional constipation to have a somatic cause of their abdominal pain instead of constipation; this is about the same percentage as in the total population (34 patients, 17 %). Faecal retention in (part of) the colon with subsequent bowel distension with or without visceral hypersensitivity could very well explain why laxatives were successful in these RAP patients [9]. Clinical studies investigating occult constipation in relation with abdominal pain are very scarce. Eidlitz-Markus et al. [4] found 29 of 68 patients with RAP to have occult constipation, which was defined as no complaints or symptoms of constipation, but hard stools on rectal examination or distended large intestines at plain abdominal X-ray. Boccia et al. [2] found functional constipation in 67 % of patients with functional dyspepsia (both according to the

4 784 Eur J Pediatr (2014) 173: Table 4 Prevalence of symptoms and odds ratio Symptoms (Occult) Other b Odds ratio c constipation a (n=92) (n=108) (Occult) constipation versus other b OR 95 % CI a (Occult) constipation including patients with both somatic disease and (occult) constipation b Other:somaticdisease(34), spontaneous recovery (54), uncertain diagnosis (13), stress (5), unresolved abdominal pain (2) c Fisher s exact test: (occult) constipation, including patients with both somatic cause and (occult) constipation, versus other patients Pain at awakening 37/92 41/ Pain with/after meals 25/92 28/ Pain with physical exercise 37/92 39/ More pain before defaecation 34/91 33/ Pain relieved by defaecation 43/88 48/ Frequently small amounts of faeces 9/92 17/ Varying consistency of stool 29/92 24/ Change in frequency at the onset of pain 22/87 27/ Change in consistency at the onset of pain 35/88 28/ Flatulence 44/92 35/ Mucus 19/90 18/ Feeling of incomplete evacuation 64/92 60/ Anorexia 52/92 60/ Early satiety 55/88 44/ Feeling of abdominal fullness 57/88 52/ Cystitis in past history 15/91 7/ Abdominal distension 10/92 14/ Abdominal/rectal faecal mass 65/92 69/ Rome II criteria), symptoms of both functional constipation and functional dyspepsia diminishing significantly with laxatives in these patients, as did the gastric emptying time. The functional dyspepsia was supposed to be the result of constipation-induced cologastric brake [14]. Keuzenkamp-Jansen et al. [10] retrospectively investigated clinical symptoms and outcome of treatment in 244 children diagnosed with constipation as assessed by plain abdominal X-ray. Of these children, 75 presented with hard and infrequent stools, while 77 had abdominal pain as the presenting symptom. It is noteworthy that, in our study, a considerable discrepancy is found between the clinical diagnosis of (occult) constipation as the cause of RAP, based on successful laxative therapy (92 patients), and functional constipation as defined bytheromeiicriteria(24/92).theromecriteriaare Table 5 Numbers of patients having up to three symptoms to predict (occult) constipation as the cause of abdominal pain Number of symptoms per patient ( three-symptom score ) Total Patients with (occult) constipation (n=92) Other (n=108) Total Symptoms: cystitis (past history), early satiety and flatulence primarily designed as the starting point of research, for which sharp definitions are necessary. In clinical practice, however, accepting broader criteria for starting laxative therapy obviously leads to recovery in a higher percentage of children with abdominal pain. In our study, Rome II criteria for functional constipation were used because Rome III criteria were not yet published at the time of inclusion of the patients. The Rome III criteria for functional constipation (for children with a developmental age of at least 4 years) combine the criteria of functional constipation and functional faecal retention of Rome II with some adjustments. Although this may change the numbers of patients to be categorised with functional constipation,this has no implications for the total number of patients diagnosed with (occult) constipation in this study, because the diagnosis was based exclusively on the results of laxative therapy. Obviously, independent whether they fitted into the Rome definition of functional constipation or were diagnosed with occult constipation, the children are suffering from a functional gastrointestinal disorder. While patients with functional constipation can be identified by symptoms according to the Rome criteria, no signs and symptoms are recognised so far that point to occult constipation. We sought to identify combinations of symptoms and signs that could lead to a diagnosis of occult and functional constipation as the cause of abdominal pain. Eighteen gastrointestinal or related variables, other than those of the Rome II

5 Eur J Pediatr (2014) 173: and III criteria of functional constipation, were analysed as to their relation with (occult) constipation. Univariate analysis showed that several of these signs and symptoms were more frequent in patients with (occult) constipation than in other patients (Table 4). Combining the three most related symptoms in a model indicated the patients with lower and higher risks of having (occult) constipation (Table 5). We suggest that at least patients with two or three of these signs and symptoms should be given laxative therapy as a therapeutic trial with regard to (occult) constipation as the cause of abdominal pain. However, the numbers are small, and a certain number of patients having none of these characteristics were found to have (occult) constipation as well. Separate analysis comparing the symptoms of patients with functional and occult constipation did not reveal any significant differences. We would like to conclude, therefore, that constipation can be diagnosed in patients lacking Rome symptoms for functional constipation; they may be considered to have occult constipation. This is the first exploratory study on risk factors for (occult) constipation. These results may serve as input for further research. The strength of this study is the systematic way in which all children referred to secondary care with RAP after having excluded gastrointestinal infections and food allergy or intolerance were treated with laxatives in order to obtain a diagnosis of (occult) constipation according to preset criteria. An important limitation is the fact that our study is an observational study, without a control group. RAP patients may have been recovered spontaneously or due to a placebo effect. In a meta-analysis, Krogsbøll et al. found average relative contributions of spontaneous improvement and of placebo to the effect of active treatment of 24 and 20 %, respectively [11]. Spiller reported placebo effects to last for approximately 12 weeks before they start to recede; by about 6 months, placebo effect is suggested to have disappeared [13]. We tried to prevent mistaking of spontaneous recovery for the supposed diagnosis by requiring disappearance of RAP in relation with the intervention, and we diminished the placebo effect as much as possible by requiring persistence of the therapeutic effect during a follow-up period of at least 6 months. Conclusion In 200 children with RAP, abdominal pain disappeared with laxative therapy and did not recur for at least 6 months in about half of the patients. They were considered to have constipation as the cause of the abdominal pain. Three quarters of these patients did not fulfil the criteria for functional constipation and therefore were considered to have occult constipation. We propose a model to identify patients at presentation to be at higher risk of having (occult) constipation, who might benefit from laxative treatment; however, no strong associations could be found between patient characteristics and (occult) constipation. Conflict of interest Funding References No financial support. No conflict of interest. 1. Apley J, Naish N (1958) Recurrent abdominal pains: a field survey of 1,000 school children. Arch Dis Child 33: Boccia G, Buonavolonta R, Coccorullo P, Manguso F, Fuiano L, Staiano A (2008) Dyspeptic symptoms in children: the result of a constipation-induced cologastric brake? Clin Gastroenterol Hepatol 6: Di Lorenzo C, Colletti RB, Lehmann HP, Boyle JT, Gerson WT, Hyams JS, Squires RH Jr, Walker LS, Kanda PT (2005) Chronic abdominal pain in children: a technical report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 40: Eidlitz-Markus T, Mimouni M, Zeharia A, Nussinovitch M, Amir J (2004) Occult constipation: a common cause of recurrent abdominal pain in childhood. Isr Med Assoc J 6: Fisher RA (1922) On the interpretation of chi square from contingency tables, and the calculation of P. J R Stat Soc 85: Gieteling MJ, Bierma-Zeinstra SM, Passchier J, Berger MY (2008) Prognosis of chronic or recurrent abdominal pain in children. J Pediatr Gastroenterol Nutr 47: Gijsbers CFM, Benninga MA, Büller HA (2011) Clinical and laboratory findings in 220 children with recurrent abdominal pain. Acta Paediatr 100: Gijsbers CFM, Kneepkens CMF, Schweizer JJ, Benninga MA, Büller HA (2011) Recurrent abdominal pain in 200 children: somatic causes and diagnostic criteria. Acta Paediatr 100:e208 e Kellow JE, Azpiroz F, Delvaux M, Gebhart GF, Mertz HR, Quigley EM, Smout AJ (2006) Applied principles of neurogastroenterology: physiology/motility sensation. Gastroenterology 130: Keuzenkamp-Jansen CW, Fijnvandraat CJ, Kneepkens CM, Douwes AC (1996) Diagnostic dilemmas and results of treatment for chronic constipation. Arch Dis Child 75: Krogsbøll LT, Hróbjartsson A, Gøtzsche PC (2009) Spontaneous improvement in randomised clinical trials: meta-analysis of threearmed trials comparing no treatment, placebo and active intervention. BMC Med Res Methodol 9: Rasquin-Weber A, Hyman PE, Cucchiara S, Fleisher DR, Hyams JS, Milla PJ, Staiano A (1999) Childhood functional gastrointestinal disorders. Gut 45(Suppl 2):II60 II Spiller RC (1999) Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. Am J Med 107:91S 97S 14. Tjeerdsma HC, Smout AJ, Akkermans LM (1993) Voluntary suppression of defecation delays gastric emptying. Dig Dis Sci 38: Wilschanski M, Branski D (2004) Recurrent abdominal pain in children: is constipation an issue? Isr Med Assoc J 6:

Constipation in childhood is characterized by a low defecation frequency in combination with either involuntary loss of

Constipation in childhood is characterized by a low defecation frequency in combination with either involuntary loss of USE OF ROME II CRITERIA IN CHILDHOOD DEFECATION DISORDERS: APPLICABILITY IN CLINICAL AND RESEARCH PRACTICE WIEGER P. VOSKUIJL, MD, JAROM HEIJMANS, HUGO S. A. HEIJMANS, MD, PHD, JAN A. J. M. TAMINIAU,MD,PHD,

More information

The involuntary loss of feces in the underwear after. Longitudinal Follow-up of Children With Functional Nonretentive Fecal Incontinence.

The involuntary loss of feces in the underwear after. Longitudinal Follow-up of Children With Functional Nonretentive Fecal Incontinence. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 26;4:67 72 Longitudinal Follow-up of Children With Functional Nonretentive Fecal Incontinence WIEGER P. VOSKUIJL,* JOHANNES B. REITSMA, RIJK VAN GINKEL,* HANS A.

More information

Constipation in children

Constipation in children Search date August 2003 Gregory Rubin QUESTIONS Effects of treatments...397 395 INTERVENTIONS CONSTIPATION Trade off between benefits and harms Cisapride with or without magnesium oxide*...397 Unknown

More information

Occult Chronic Functional Constipation: An Overlooked Cause of Reversible Hydronephrosis in Childhood K Akl ABSTRACT

Occult Chronic Functional Constipation: An Overlooked Cause of Reversible Hydronephrosis in Childhood K Akl ABSTRACT Occult Chronic Functional Constipation: An Overlooked Cause of Reversible Hydronephrosis in Childhood K Akl ABSTRACT Objective: The aim of this study is to find out if there is any relationship between

More information

Comparing the efficacy of polyethylene glycol. glycol (PEG), magnesium hydroxide, lactulose. treatment of functional constipation in children

Comparing the efficacy of polyethylene glycol. glycol (PEG), magnesium hydroxide, lactulose. treatment of functional constipation in children Original article Comparing the efficacy of polyethylene glycol (PEG), magnesium hydroxide and lactulosein treatment of functional constipation in children Hossein Saneian 1, Neda Mostofizadeh 2 1 Assistant

More information

ABDOMINAL PAIN, CHRONIC

ABDOMINAL PAIN, CHRONIC Introduction Incidence Aetiology Clinical Assessment Formulation Investigations Management Prognosis Conclusion References Introduction The generally accepted definition of this condition is three or more

More information

Bowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care

Bowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care Bowel cancer risk in the under 50s Greg Rubin Professor of General Practice and Primary Care Prevalence of GI problems in the consulting population Thompson et al, Gut 2000 Number of patients % of patients

More information

CHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University

CHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University CHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University 1 Definition of FGID Chronic and recurrent symptoms of the gastrointestinal

More information

Authors and Disclosures

Authors and Disclosures Role of Carbon Dioxide-Releasing Suppositories in the Treatment of Chronic Functional Constipation A Double-Blind, Randomised, Placebo-Controlled Trial M. Lazzaroni; V. Casini; G. Bianchi Porro Authors

More information

ABDOMINAL PAIN, CHRONIC

ABDOMINAL PAIN, CHRONIC Introduction Incidence Aetiology Clinical Assessment Formulation Investigations Management Prognosis Conclusion References Introduction The generally accepted definition of this condition is three or more

More information

SUPPLEMENTARY INFORMATION Associated with

SUPPLEMENTARY INFORMATION Associated with Table1: Rome III and Rome IV diagnostic criteria for IBS, functional constipation and functional dyspepsia. Rome III diagnostic criteria 1,2 Rome IV diagnostic criteria 3,4 Diagnostic criteria for IBS

More information

Paediatric constipation and functional non-retentive faecal soiling Voskuijl, W.P.

Paediatric constipation and functional non-retentive faecal soiling Voskuijl, W.P. UvA-DARE (Digital Academic Repository) Paediatric constipation and functional non-retentive faecal soiling Voskuijl, W.P. Link to publication Citation for published version (APA): Voskuijl, W. P. (2005).

More information

Initial Diagnosis of Functional Gastrointestinal Disorders in Children Increases a Chance for Resolution of Symptoms

Initial Diagnosis of Functional Gastrointestinal Disorders in Children Increases a Chance for Resolution of Symptoms pissn: 2234-8646 eissn: 2234-8840 https://doi.org/10.5223/pghn.2018.21.4.264 Pediatr Gastroenterol Hepatol Nutr 2018 October 21(4):264-270 Original Article PGHN Initial Diagnosis of Functional Gastrointestinal

More information

15. Prevention of UTI and lifestyle modifications

15. Prevention of UTI and lifestyle modifications 15. Prevention of UTI and lifestyle modifications Key questions: Does improving poor voiding habits help prevent UTI recurrence? Does improving constipation help prevent UTI recurrence? Does increasing

More information

Therapeutic Response for Functional Abdominal Pain in Children with Occult Constipation: Laxatives versus Prokinetic Drugs

Therapeutic Response for Functional Abdominal Pain in Children with Occult Constipation: Laxatives versus Prokinetic Drugs ORIGINAL ARTICLE Pediatrics https://doi.org/10.3346/jkms.2017.32.1.102 J Korean Med Sci 2017; 32: 102-107 Therapeutic Response for Functional Abdominal Pain in Children with Occult Constipation: Laxatives

More information

COMMON PROBLEMS IN PAEDIATRIC GASTROENTEROLOGY AKSHAY BATRA CONSULTANT PAEDIATRIC GASTROENTEROLOGIST

COMMON PROBLEMS IN PAEDIATRIC GASTROENTEROLOGY AKSHAY BATRA CONSULTANT PAEDIATRIC GASTROENTEROLOGIST COMMON PROBLEMS IN PAEDIATRIC GASTROENTEROLOGY AKSHAY BATRA CONSULTANT PAEDIATRIC GASTROENTEROLOGIST Paediatric Gastroenterology : Referral Base Common problems Feeding difficulties in infancy Recurrent

More information

Classification of pediatric functional gastrointestinal disorders related to abdominal pain using Rome III vs. Rome IV criterions

Classification of pediatric functional gastrointestinal disorders related to abdominal pain using Rome III vs. Rome IV criterions Edwards et al. BMC Gastroenterology (2018) 18:41 https://doi.org/10.1186/s12876-018-0769-z RESEARCH ARTICLE Open Access Classification of pediatric functional gastrointestinal disorders related to abdominal

More information

Chronic constipation, often accompanied by encopresis. Childhood Constipation: Longitudinal Follow-up Beyond Puberty. Patients and Methods

Chronic constipation, often accompanied by encopresis. Childhood Constipation: Longitudinal Follow-up Beyond Puberty. Patients and Methods GASTROENTEROLOGY 2003;125:357 363 Childhood Constipation: Longitudinal Follow-up Beyond Puberty RIJK VAN GINKEL,* JOHANNES B. REITSMA, HANS A. BÜLLER, MICHIEL P. VAN WIJK,* JAN A. J. M. TAMINIAU,* and

More information

Functional Dyspepsia

Functional Dyspepsia Functional Dyspepsia American College of Gastroenterology Boston Massachusetts, June 2015 Brian E. Lacy, PhD, MD, FACG Professor of Medicine Geisel School of Medicine at Dartmouth Chief, Section of Gastroenterology

More information

CLINICAL REVIEW. Irritable bowel syndrome

CLINICAL REVIEW. Irritable bowel syndrome For the full versions of these articles see bmj.com CLINICAL REVIEW Chronic abdominal pain in children M Y Berger, 1 M J Gieteling, 1 M A Benninga 2 1 Department of General Practice, Erasmus MC, University

More information

Dyspeptic Symptoms in Children: The Result of a Constipation-Induced Cologastric Brake?

Dyspeptic Symptoms in Children: The Result of a Constipation-Induced Cologastric Brake? CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2008;6:556 560 Dyspeptic Symptoms in Children: The Result of a Constipation-Induced Cologastric Brake? GABRIELLA BOCCIA,* ROBERTA BUONAVOLONTÀ,* PAOLA COCCORULLO,*

More information

OPIOID-INDUCED CONSTIPATION DR ANDREW DAVIES

OPIOID-INDUCED CONSTIPATION DR ANDREW DAVIES OPIOID-INDUCED CONSTIPATION DR ANDREW DAVIES Introduction Introduction Mean faecal weight 128 g / cap / day Mean range 51-796 g Absolute range 15-1505 g Main factors affecting mass are caloric intake,

More information

Starreveld scoring method in diagnosing childhood constipation

Starreveld scoring method in diagnosing childhood constipation Pediatr Radiol (2010) 40:1789 1793 DOI 10.1007/s00247-010-1725-4 ORIGINAL ARTICLE Starreveld scoring method in diagnosing childhood constipation Fredericus T. Kokke & Judith S. Sittig & Annemiek de Bruijn

More information

Diagnostic dilemmas and results of treatment for

Diagnostic dilemmas and results of treatment for 36 Department of Paediatrics, Free University Hospital, PO Box 757, 17 MB Amsterdam, The Netherlands CW Keuzenkamp-Jansen CJ Fijnvandraat CMF Kneepkens AC Douwes Correspondence and reprint requests to:

More information

IBS - Definition. Chronic functional disorder of GI generally characterized by:

IBS - Definition. Chronic functional disorder of GI generally characterized by: IBS - Definition Chronic functional disorder of GI generally characterized by: 3500 3000 No. of Publications 2500 2000 1500 1000 Irritable Bowel syndrome Irritable Bowel Syndrome 500 0 1968-1977 1978-1987

More information

University Medical Center at Brackenridge. Gastroenterology Clinic Worksheet

University Medical Center at Brackenridge. Gastroenterology Clinic Worksheet Gastroenterology Clinic Worksheet 1. GI Bleeding (occult or symptomatic) a. CBC b. Iron, Ferritin b. Medication history 2. Iron Deficiency Anemia and no evident source (if no iron deficiency consider hematological

More information

C onstipation is a common problem in children, accounting

C onstipation is a common problem in children, accounting 723 ORIGINAL ARTICLE Prognosis of constipation: clinical factors and colonic transit time F de Lorijn, M P van Wijk, J B Reitsma, R van Ginkel, J A J M Taminiau, M A Benninga... See end of article for

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Constipation: management of idiopathic constipation in children in primary and secondary care 1.1 Short title Constipation

More information

PELVIC PAIN : Gastroenterological Conditions

PELVIC PAIN : Gastroenterological Conditions PELVIC PAIN : Gastroenterological Conditions Departman Tarih Prof. A. Melih OZEL, MD Department of Gastroenterology Anadolu Medical Center Hospital Gebze Kocaeli - TURKEY Presentation plan 15 min. Introduction

More information

... SELECTED ABSTRACTS...

... SELECTED ABSTRACTS... ... SELECTED ABSTRACTS... The following abstracts, from medical journals containing literature on irritable bowel syndrome, were selected for their relevance to this supplement. A Technical Review for

More information

Active ingredients per ml: Docusate sodium 1 mg/sorbitol solution (70%) (crystallising) 357 mg Structural formula: Docusate.

Active ingredients per ml: Docusate sodium 1 mg/sorbitol solution (70%) (crystallising) 357 mg Structural formula: Docusate. NAME OF THE MEDICINE KLYX Enema Active ingredients per ml: Docusate sodium 1 mg/sorbitol solution (70%) (crystallising) 357 mg Structural formula: Docusate Sorbitol C20H37NaO7S MW: 444.56 CAS no: 577-11-7

More information

Childhood constipation, a real problem..? Marc Benninga, Emma Children s Hospital, AMC, Amsterdam, the Netherlands

Childhood constipation, a real problem..? Marc Benninga, Emma Children s Hospital, AMC, Amsterdam, the Netherlands Childhood constipation, a real problem..? Marc Benninga, Emma Children s Hospital, AMC, Amsterdam, the Netherlands Constipation 0-10% >10-20% >20-30% >30-40% Mugie SM, et al. Best Pract & Res Clin Gastroenterol

More information

The long-term impact of the low-fodmap diet for management of irritable bowel syndrome. Dr Miranda Lomer RD.

The long-term impact of the low-fodmap diet for management of irritable bowel syndrome. Dr Miranda Lomer RD. The long-term impact of the low-fodmap diet for management of irritable bowel syndrome Dr Miranda Lomer RD Email: miranda.lomer@kcl.ac.uk What is IBS - ROME IV Criteria A functional bowel disorder in which

More information

TREATMENT SOCIETY GUIDELINES FOR CONSTIPATION: WHAT IS NEW? FUNCTIONAL CONSTIPATION

TREATMENT SOCIETY GUIDELINES FOR CONSTIPATION: WHAT IS NEW? FUNCTIONAL CONSTIPATION SOCIETY GUIDELINES FOR CONSTIPATION: WHAT IS NEW? Samuel Nurko MD MPH Center for Motility and Functional Gastrointestinal Disorders FUNCTIONAL CONSTIPATION One of the most common functional GI disorders

More information

Biofeedback for Pelvic Floor Disorders and Incontinence

Biofeedback for Pelvic Floor Disorders and Incontinence The UNC Center for Functional GI & Motility Disorders www.med.unc.edu/ibs Biofeedback for Pelvic Floor Disorders and Incontinence Olafur S. Palsson, Psy.D. Associate Professor of Medicine UNC Center for

More information

Irritable bowel syndrome in adults

Irritable bowel syndrome in adults Irritable bowel syndrome in adults NICE provided the content for this booklet which is independent of any company or product advertised Welcome In February 2008, NICE published a clinical guideline on

More information

Constipation and functional faecal retention in a group of school children in a district in Sri Lanka

Constipation and functional faecal retention in a group of school children in a district in Sri Lanka Constipation and functional faecal retention in a group of school children in a district in Sri Lanka Shaman Rajindrajith 1, Niranga Manjuri Devanarayana 2, Sachith Mettananda 3, Priyantha Perera 1, Sanofer

More information

Diagnosing and Managing IBS in IBD Patients. September 2012

Diagnosing and Managing IBS in IBD Patients. September 2012 Diagnosing and Managing IBS in IBD Patients September 2012 Professor David S Sanders Consultant Gastroenterologist Royal Hallamshire Hospital & University of Sheffield Patient Comes to see you with GI

More information

190 Index Case studies, abdominal pain, 2 Crohn s disease, 2 3, cyclic vomiting syndrome (CVS), 2 fecal incontinence (FI), 2 medical c

190 Index Case studies, abdominal pain, 2 Crohn s disease, 2 3, cyclic vomiting syndrome (CVS), 2 fecal incontinence (FI), 2 medical c Index Abdominal pain, case study, 2 Achalasia, 75 Acupuncture 108 American Academy of Pediatrics, 49 Anxiety, 8 9, 98 Autism, GI disorders and, 25 27 BASC. See Behavior Assessment System for Children (BASC)

More information

MOVICOL HALF PI December MOVICOL-Half. Powder for Solution (macrogol 3350) Potassium 5.4 mmol/l. Bicarbonate 17 mmol/l

MOVICOL HALF PI December MOVICOL-Half. Powder for Solution (macrogol 3350) Potassium 5.4 mmol/l. Bicarbonate 17 mmol/l MOVICOL -Half Powder for Solution (macrogol 3350) Product Name: Product Description: MOVICOL-Half Each sachet of MOVICOL-Half contains: Macrogol 3350 6.563 g Sodium chloride 175.4 mg Sodium bicarbonate

More information

Functional constipation in children: which treatment is effective and safe? An evidence-based case report

Functional constipation in children: which treatment is effective and safe? An evidence-based case report Functional constipation in children: which treatment is effective and safe? An evidence-based case report 1. Private practice, Quebec, Canada. Email: nathaelle@chirostmartin.com By Nathaëlle Martin-Marcotte,

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT OF DYSPEPSIA o Patients of any age with ALARM signs should be referred through the 2-week referral system o Routine endoscopic investigation

More information

PELVIC PAIN : Gastroenterological Conditions

PELVIC PAIN : Gastroenterological Conditions PELVIC PAIN : Gastroenterological Conditions Departman Tarih Prof. A. Melih OZEL, MD Department of Gastroenterology Anadolu Medical Center Hospital Gebze Kocaeli - TURKEY Presentation plan 15 min. Introduction

More information

Treat primary. symptoms. Offer general lifestyle advice. Manage IBS according to the dominant symptom. Follow up. Symptoms do not improve

Treat primary. symptoms. Offer general lifestyle advice. Manage IBS according to the dominant symptom. Follow up. Symptoms do not improve Treat primary symptoms Background information for clinicians Offer general lifestyle advice Background information for patients Manage IBS according to the dominant symptom Provenance Psychological symptoms

More information

MOVICOL Junior Powder for Solution (macrogol 3350)

MOVICOL Junior Powder for Solution (macrogol 3350) MOVICOL Junior Powder for Solution (macrogol 3350) Product Name: MOVICOL Junior Product Description: Each sachet of MOVICOL Junior contains: Macrogol 3350 Sodium chloride Sodium bicarbonate Potassium chloride

More information

WOMEN WITH IRRITABLE BOWEL SYNDROME ACCORDING TO ROME II CRITERIA IN JORDAN

WOMEN WITH IRRITABLE BOWEL SYNDROME ACCORDING TO ROME II CRITERIA IN JORDAN Original Article WOMEN WITH IRRITABLE BOWEL SYNDROME ACCORDING TO ROME II CRITERIA IN JORDAN Kassab Harfoushi 1 ABSTRACT Objectives: To characterize the possible risk factors, clinical features and outcome

More information

An Approach to Abdominal Pain

An Approach to Abdominal Pain An Approach to Abdominal Pain objectives Should know the different types of abd pain Is acute or chronic? Hx taking skills with knowing the key questions Important abdominal pain signs A good differential

More information

Food Choices and Alternative Techniques in Management of IBS: Fad Versus Evidence

Food Choices and Alternative Techniques in Management of IBS: Fad Versus Evidence Food Choices and Alternative Techniques in Management of IBS: Fad Versus Evidence Maria Vazquez Roque, MD, MSc Assistant Professor Gastroenterology and Hepatology 2010 MFMER slide-1 Objectives Gluten-free

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lacrofarm Junior, powder for oral solution, sachet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of contains the following active

More information

Elderly Man With Chronic Constipation

Elderly Man With Chronic Constipation Elderly Man With Chronic Constipation Linda Nguyen, MD Director, Neurogastroenterology and Motility Clinical Assistant Professor Stanford University Overview Normal bowel function Defining Constipation:

More information

Irritable Bowel Syndrome Now. George M. Logan, MD Friday, May 5, :35 4:05 PM

Irritable Bowel Syndrome Now. George M. Logan, MD Friday, May 5, :35 4:05 PM Irritable Bowel Syndrome Now George M. Logan, MD Friday, May 5, 2017 3:35 4:05 PM Dr. Logan indicated no potential conflict of interest to this presentation. He does not intend to discuss any unapproved/investigative

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Constipation: the diagnosis and management of idiopathic childhood constipation in primary and secondary care 1.1 Short title

More information

Primary Management of Irritable Bowel Syndrome

Primary Management of Irritable Bowel Syndrome Primary Management of Irritable Bowel Syndrome Jasmine Zia, MD Acting Instructor, Division of Gastroenterology Current Concepts in Drug Therapy CME Course April 23, 2015 Irritable Bowel Syndrome (IBS)

More information

Package leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides

Package leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides Package leaflet: Information for the user SenEase 7.5 mg tablets Sennosides Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep

More information

Digestion. Text. What You Don t Know Can Hurt You!

Digestion. Text. What You Don t Know Can Hurt You! Digestion Text What You Don t Know Can Hurt You! Digestive Problems Approximately 36.5 million visits annually to ambulatory care facilities due to the diseases of the digestive system Over 4 million ulcers

More information

SYMPROIC (naldemedine tosylate) oral capsule

SYMPROIC (naldemedine tosylate) oral capsule SYMPROIC (naldemedine tosylate) oral capsule Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This

More information

Supplemental Table 1: Moderate and severe definitions of Celiac Disease Symptom Diary

Supplemental Table 1: Moderate and severe definitions of Celiac Disease Symptom Diary Supplemental Table 1: Moderate and severe definitions of Celiac Disease Symptom Diary symptoms CDSD Symptom Diarrhea Constipation Abdominal Pain Bloating Nausea Tiredness Moderate Once or twice between

More information

Constipation is a common disorder in children,

Constipation is a common disorder in children, The Effect of Anorectal Manometry on the Outcome of Treatment in Severe Childhood Constipation: A Randomized, Controlled Trial Rijk van Ginkel, MD*; Hans A. Büller, PhD ; Guy E. Boeckxstaens, PhD ; Roos

More information

Prescribing Guidance for the Treatment of Constipation in Children

Prescribing Guidance for the Treatment of Constipation in Children Prescribing Guidance for the Treatment of Constipation in Children Effective Date: July 2007 Reviewed: September 2009 & December 2011 Review Date: December 2013 Gateshead Medicines Management Approved

More information

INTERNATIONAL PROSPECTIVE STUDY ON DISTAL INTESTINAL OBSTRUCTION SYNDROME (DIOS). ASSOCIATED FACTORS and OUTCOMES..

INTERNATIONAL PROSPECTIVE STUDY ON DISTAL INTESTINAL OBSTRUCTION SYNDROME (DIOS). ASSOCIATED FACTORS and OUTCOMES.. INTERNATIONAL PROSPECTIVE STUDY ON DISTAL INTESTINAL OBSTRUCTION SYNDROME (DIOS). ASSOCIATED FACTORS and OUTCOMES.. Anne Munck1, Corinne Alberti 1, Priscilla Boizeau 1, Carla Colombo2 Natalia Kashirskaya

More information

Pediatric Gastroenterology Referral Guidelines

Pediatric Gastroenterology Referral Guidelines Suggested Pre-Referral Workup This is a general suggestion of possible testing to confirm a suspected diagnosis. Although referrals will be accepted without the suggested work up being complete, to ensure

More information

Technology appraisal guidance Published: 15 December 2010 nice.org.uk/guidance/ta211

Technology appraisal guidance Published: 15 December 2010 nice.org.uk/guidance/ta211 Prucalopride for the treatment of chronic constipation in women Technology appraisal guidance Published: 15 December 2010 nice.org.uk/guidance/ta211 NICE 2018. All rights reserved. Subject to Notice of

More information

Technology appraisal guidance Published: 23 July 2014 nice.org.uk/guidance/ta318

Technology appraisal guidance Published: 23 July 2014 nice.org.uk/guidance/ta318 Lubiprostone for treating chronic idiopathic constipation Technology appraisal guidance Published: 23 July 2014 nice.org.uk/guidance/ta318 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

There are clues to help to decide if the bellyache is a medical problem:

There are clues to help to decide if the bellyache is a medical problem: Bellyaches in Children Pediatric and Adolescent Gastrointestinal Motility & Pain Program Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, Louisiana By: Paul Hyman,

More information

Etiology and Clinical Spectrum of Constipation in Indian Children

Etiology and Clinical Spectrum of Constipation in Indian Children R E S E A R C H P A P E R Etiology and Clinical Spectrum of Constipation in Indian Children VIKRANT KHANNA*, UJJAL PODDAR AND SURENDER KUMAR YACHHA From the Departments of Pediatric Gastroenterology and

More information

Presenter. Irritable Bowel Syndrome. Objectives. Introduction. Rome Criteria. Irritable Bowel Syndrome 2/28/2018

Presenter. Irritable Bowel Syndrome. Objectives. Introduction. Rome Criteria. Irritable Bowel Syndrome 2/28/2018 Presenter Irritable Bowel Syndrome Current evidence for diagnosis & management Julie Daniels DNP, CNM Assistant Professor Course Coordinator of Primary Care of Women Faculty at Frontier Nursing University

More information

David Leff, DO. April 13, Disclosure. I have the following financial relationships to disclosure:

David Leff, DO. April 13, Disclosure. I have the following financial relationships to disclosure: David Leff, DO AOMA 94 th Annual Convention April 13, 2016 Disclosure I have the following financial relationships to disclosure: Speaker s Bureau: Allergan Labs, Takeda Pharmaceutical, Valeant Pharmaceutical

More information

MOVICOL Junior Chocolate Flavour Powder for Solution (macrogol 3350)

MOVICOL Junior Chocolate Flavour Powder for Solution (macrogol 3350) MOVICOL Junior Chocolate Flavour Powder for Solution (macrogol 3350) Product Name: MOVICOL Junior Chocolate Flavour Product Description: Each sachet of MOVICOL Junior Chocolate contains: Macrogol 3350

More information

2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of Macrovic Junior powder for oral solution contains the following active ingredients:

2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of Macrovic Junior powder for oral solution contains the following active ingredients: SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Macrovic Junior powder for oral solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of Macrovic Junior powder for oral solution

More information

A Randomized Open Label Comparative Clinical Study of a Probiotic against a Symbiotic in the Treatment of Acute Diarrhoea in Children

A Randomized Open Label Comparative Clinical Study of a Probiotic against a Symbiotic in the Treatment of Acute Diarrhoea in Children International Journal of Medical Research & Health Sciences Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(9): 96-100 I J M R

More information

Opioid Induced Constipation Lisa Clince Acute Pain CNS Palmerston North Hospital

Opioid Induced Constipation Lisa Clince Acute Pain CNS Palmerston North Hospital Opioid Induced Constipation Lisa Clince Acute Pain CNS Palmerston North Hospital 21-04-2016 MidCentral District Health Board 1 Overview Patient Experience Opioid Collaborative Constipation defined Opioid

More information

Clinical guideline Published: 23 February 2008 nice.org.uk/guidance/cg61

Clinical guideline Published: 23 February 2008 nice.org.uk/guidance/cg61 Irritable bowel syndrome in adults: diagnosis and management Clinical guideline Published: 23 February 2008 nice.org.uk/guidance/cg61 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Functional Heartburn and Dyspepsia

Functional Heartburn and Dyspepsia Functional Heartburn and Dyspepsia Nicholas Shaheen, MD, MPH Center for Esophageal Diseases and Swallowing University of North Carolina Objectives Understand the means of diagnosing functional heartburn

More information

Correlation of bowel habits with physical activity and fibre intake

Correlation of bowel habits with physical activity and fibre intake Original Article Brunei Int Med J. 2013; 9 (6): 358-365 Correlation of bowel habits with physical activity and fibre intake Nurulhuda PENGIRAN MUSA 1, Salim FREDERICK 1, Vui Heng CHONG 2 1 PAPRSB Institute

More information

Treatment of functional constipation in children: Evidence-based recommendations from ESPGHAN and NASPGHAN 2014

Treatment of functional constipation in children: Evidence-based recommendations from ESPGHAN and NASPGHAN 2014 Treatment of functional constipation in children: Evidence-based recommendations from ESPGHAN and NASPGHAN 2014 BS. Nguyễn Thị Kim Ngân Khoa Tiêu Hóa BV Nhi Đồng 2 Introduction Constipation is a common

More information

CONSTIPATION. Atan Baas Sinuhaji

CONSTIPATION. Atan Baas Sinuhaji CONSTIPATION Atan Baas Sinuhaji Sub Division of Pediatrics Gastroentero-Hepatolgy Department of ChildHealth,School of Medicine University of Sumatera Utara MEDAN DEFECATION REGULAR PATTERN CONSTIPATION

More information

Recurrent Abdominal Pain: an Etiological Study among in a Referreal Children's Medical Center in Iran

Recurrent Abdominal Pain: an Etiological Study among in a Referreal Children's Medical Center in Iran Original Article Iran J Ped Sep 2007; Vol 17 ( No 3), Pp:235-240 Recurrent Abdominal Pain: an Etiological Study among in a Referreal Children's Medical Center in Iran Touran shahraki 1, Fatemeh Farahmand

More information

Primary Care Constipation Guidelines. Version 1 November 2016

Primary Care Constipation Guidelines. Version 1 November 2016 Primary Care Constipation Guidelines Version 1 November 2016 VERSION CONTROL Version Date Amendments made Version 1 November 2016 New guideline Contents 1. Management of constipation in adults: acute and

More information

Is one of the most common chronic disorders. causing patients to seek medical treatment.

Is one of the most common chronic disorders. causing patients to seek medical treatment. ILOs After this lecture you should be able to : Define IBS Identify causes and risk factors of IBS Determine the appropriate therapeutic options for IBS Is one of the most common chronic disorders causing

More information

Gastrointestinal Involvement in Adult Mitochondrial Disease

Gastrointestinal Involvement in Adult Mitochondrial Disease Newcastle Mitochondrial Disease Guidelines At a glance guidelines: Gastrointestinal Involvement in Adult Mitochondrial Disease For full guideline visit: http://www.newcastle-mitochondria.com/service/patient-care-guidelines/

More information

Do Probiotics Provide Adequate Relief From Overall Symptoms, Including Abdominal Pain and Bloating, in Adults With Irritable Bowel Syndrome?

Do Probiotics Provide Adequate Relief From Overall Symptoms, Including Abdominal Pain and Bloating, in Adults With Irritable Bowel Syndrome? Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2015 Do Probiotics Provide Adequate Relief

More information

6/25/ % 20% 50% 19% Functional Dyspepsia Peptic Ulcer GERD Cancer Other

6/25/ % 20% 50% 19% Functional Dyspepsia Peptic Ulcer GERD Cancer Other Peptic Ulcer Disease and Dyspepsia John M. Inadomi, MD Professor of Medicine UCSF Chief, Clinical Gastroenterology San Francisco General Hospital Case History 49 y/o woman complains of several months of

More information

Recurrent Abdominal Pain in Children: A Review

Recurrent Abdominal Pain in Children: A Review Review Article Recurrent Abdominal Pain in Children: A Review Alam R 1, Sarkar PC 2, Saibal AA 3 Abstract: Recurrent abdominal pain (RAP) in children is a common pediatric problem encountered by primary

More information

Weekly Prevalence of Symptoms USA vs. Colombia

Weekly Prevalence of Symptoms USA vs. Colombia THE OVERLAP BETWEEN INFLAMMATORY BOWEL DISEASE AND FUNCTIONAL GASTROINTESTINAL DISORDERS: CHALLENGES AND TREATMENT IMPLICATIONS Miguel Saps, MD Professor of Pediatrics, Ohio State University Director of

More information

Abdominal pain-related functional gastrointestinal disorders based on Rome III criteria in a pediatric gastroenterology clinic

Abdominal pain-related functional gastrointestinal disorders based on Rome III criteria in a pediatric gastroenterology clinic Original Article Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences Abdominal pain-related functional gastrointestinal disorders based on Rome III criteria in a

More information

Diagnosis and Management of Irritable Bowel Syndrome (IBS) For the Primary Care Provider

Diagnosis and Management of Irritable Bowel Syndrome (IBS) For the Primary Care Provider Diagnosis and Management of Irritable Bowel Syndrome (IBS) For the Primary Care Provider Elizabeth Coss, MD General Gastroenterologist Audie Murphy Veterans Hospital UT Health This presentation does not

More information

Journal of American Science 2017;13(6) Celiac Disease in Patients with Irritable Bowel Syndrome

Journal of American Science 2017;13(6)   Celiac Disease in Patients with Irritable Bowel Syndrome Celiac Disease in Patients with Irritable Bowel Syndrome Ahmed Abdelmoaty Elnaggar, MD 1, Waleed El Nabawy, MD, Mohammed Ibrahim Atta, MD 1 Internal Medicine Department, Faculty of Medicine, Cairo University,

More information

Irritable Bowel Disease. Dr. Alexandra Ilnyckyj MD

Irritable Bowel Disease. Dr. Alexandra Ilnyckyj MD Irritable Bowel Disease Dr. Alexandra Ilnyckyj MD Exactly what is IBS? Common condition affecting mostly women Symptoms are variable but they reflect altered gut movement (motility) and sensation Commonly

More information

High Prevalence of Nausea in Children With Pain-Associated Functional Gastrointestinal Disorders: Are Rome Criteria Applicable?

High Prevalence of Nausea in Children With Pain-Associated Functional Gastrointestinal Disorders: Are Rome Criteria Applicable? ORIGINAL ARTICLE: GASTROENTEROLOGY High Prevalence of Nausea in Children With Pain-Associated Functional Gastrointestinal Disorders: Are Rome Criteria Applicable? Katja Kovacic, Sara Williams, B U.K. Li,

More information

A Guide to Gastrointestinal Motility Disorders

A Guide to Gastrointestinal Motility Disorders A Guide to Gastrointestinal Motility Disorders Albert J. Bredenoord André Smout Jan Tack A Guide to Gastrointestinal Motility Disorders Albert J. Bredenoord Gastroenterology and Hepatology Academic Medical

More information

Medical Policy. MP Ingestible ph and Pressure Capsule

Medical Policy. MP Ingestible ph and Pressure Capsule Medical Policy BCBSA Ref. Policy: 2.01.81 Last Review: 11/15/2018 Effective Date: 11/15/2018 Section: Medicine Related Policies 2.01.20 Esophageal ph Monitoring 6.01.33 Wireless Capsule Endoscopy as a

More information

Xifaxan, Lotronex and Viberzi Prior Authorization and Quantity Limit Program Summary

Xifaxan, Lotronex and Viberzi Prior Authorization and Quantity Limit Program Summary Xifaxan, Lotronex and Viberzi Prior Authorization and Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1,2 Lotronex (alosetron) a Indication For women with severe diarrheapredominant irritable

More information

Thornton Natural Healthcare s Better Health News

Thornton Natural Healthcare s Better Health News August, 2010 Volume 5, Issue 8 Thornton Natural Healthcare s Better Health News www.thornton-health.com Special Interest Articles: Vitamin K Probiotics and IBS IBS Food sensitivity and IBS Mercury and

More information

Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome: A meta-analysis of randomized controlled trials

Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome: A meta-analysis of randomized controlled trials Clinical research Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome: A meta-analysis of randomized controlled trials Roja Rahimi 1, Shekoufeh Nikfar 2, Mohammad Abdollahi

More information

Chapter 1. General introduction and outline

Chapter 1. General introduction and outline Chapter 1 General introduction and outline General introduction The function of the stomach comprises storage of ingested food, production of gastric secretion and mixing food with gastric secretion,

More information

JOURNAL OF THE ROYAL SOCIETY OF MEDICINE Volume 98 March J R Soc Med 2005;98: SECTION OF PAEDIATRICS AND CHILD HEALTH 27 APRIL 2004

JOURNAL OF THE ROYAL SOCIETY OF MEDICINE Volume 98 March J R Soc Med 2005;98: SECTION OF PAEDIATRICS AND CHILD HEALTH 27 APRIL 2004 Recurrent abdominal pain in childhood APlunkett MRCPCH R M Beattie FRCPClin J R Soc Med 2005;98:101 106 SECTION OF PAEDIATRICS AND CHILD HEALTH 27 APRIL 2004 Recurrent abdominal pain is a frequent presenting

More information

(minutes for web publishing)

(minutes for web publishing) Gastrointestinal Subcommittee of the Pharmacology and Therapeutics Advisory Committee (PTAC) Meeting held on 28 March 2017 (minutes for web publishing) Gastrointestinal Subcommittee minutes are published

More information

Disclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome

Disclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome Gastrointestinal Motility Disorders & Irritable Bowel Syndrome None Disclosures Jasmine Zia, MD Acting Assistant Professor Division of Gastroenterology, University of Washington 6 th Asian Health Symposium

More information

Technology appraisal guidance Published: 30 August 2017 nice.org.uk/guidance/ta471

Technology appraisal guidance Published: 30 August 2017 nice.org.uk/guidance/ta471 Eluxadoline for treating irritable bowel syndrome with diarrhoea Technology appraisal guidance Published: 30 August 2017 nice.org.uk/guidance/ta471 NICE 2017. All rights reserved. Subject to Notice of

More information

Development of a core outcome set for clinical trials in childhood constipation: a study using a Delphi technique

Development of a core outcome set for clinical trials in childhood constipation: a study using a Delphi technique BMJ Paediatrics Open To cite: Kuizenga-Wessel S, Steutel NF, Benninga MA, et al. Development of a core outcome set for clinical trials in childhood constipation: a study using a Delphi technique. BMJ Paediatrics

More information